News

The drug elafibranor appears to be effective and safe for the treatment of primary biliary cholangitis (PBC) in a phase 3 trial.

Using a two-sample Mendelian randomization (MR) analysis, researchers found a genetic association between PBC and CTDs.

Phase 1 results showed TH104 had a positive safety and efficacy profile, and Tharimmune is on track to begin a phase 2 study this year.

A randomized survival forest model in machine learning was used to construct a prognostic model for cirrhosis in primary biliary cholangitis (PBC).

A study showed a rare case of primary biliary cholangitis (PBC) with features of autoimmune hepatitis in an adolescent with a genetic defect.

Autotaxin may be an effective noninvasive biomarker for the diagnosis and prognosis of primary biliary cholangitis (PBC), researchers stated.

The formation of liver abscess caused by Klebsiella pneumoniae can be life-threatening in patients with primary sclerosing cholangitis (PSC).

Ultrasound imaging may be a valuable tool to assess and predict the progression of primary biliary cholangitis (PBC), according to a study.

The latest findings from a post-hoc analysis of the phase 3 ENHANCE study were published in the journal Hepatology,

A recent study shows intense itching, also known as pruritus, significantly reduces the life quality of patients with primary biliary cholangitis (PBC).